Olimel 5.7% 8 g (Soybean Oil EMULSION) 8 G

OlimeL 5.7% 8G is an intravenous emulsion containing soybean oil, designed for nutritional support. This product is formulated to provide essential fatty acids and calories for patients requiring parenteral nutrition.

Strength

8 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OlimeL 5.7% 8G is primarily used for intravenous nutrition, supplying essential fatty acids and calories. It is often utilized in clinical settings where oral or enteral nutrition is not feasible, supporting overall nutritional needs and helping maintain energy levels.

Side Effects

When administered intravenously, OlimeL 5.7% 8G provides essential nutrients directly into the bloodstream. It helps support metabolic functions and can contribute to overall health and well-being in patients who require parenteral nutrition.

Precautions & Warnings

OlimeL 5.7% 8G should be handled with care, ensuring proper storage and administration protocols are followed. It is important to use this product under medical supervision to avoid potential complications. Always check for any signs of contamination or damage before use.

Avoid Interactions

OlimeL 5.7% 8G may interact with other medications or supplements being administered intravenously. It is crucial to consult healthcare professionals to manage potential interactions, especially with other intravenous treatments or medications that affect metabolism.

Frequently Asked Questions

OlimeL 5.7% 8G is used for intravenous nutrition, providing essential fatty acids and calories to patients who cannot consume nutrients orally or enterally.

OlimeL 5.7% 8G is administered intravenously, typically in a clinical setting under medical supervision.

OlimeL 5.7% 8G provides essential nutrients directly into the bloodstream, supporting metabolic functions and overall health.

Yes, OlimeL 5.7% 8G should be handled with care, ensuring proper storage and administration protocols are followed to avoid potential complications.

OlimeL 5.7% 8G may interact with other medications or supplements being administered intravenously, so it is important to consult healthcare professionals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.